Are you Dr. Matin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 95 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-794-4824
Summary
- Dr. Surena Matin, MD is a board certified urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Surgery.
Education & Training
- Cleveland Clinic FoundationResidency, Urology, 1994 - 2000
- Weill Cornell MedicineClass of 1994
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer Start of enrollment: 2020 Jul 28
Publications & Presentations
PubMed
- Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial.Sumanta K Pal, Petros Grivas, Shilpa Gupta, Nazli Dizman, Zeynep Zengin
European Urology. 2025-02-01 - Durability of response of UGN-101: Longitudinal follow up of multicenter study.Solomon L Woldu, Daniel Igel, Brett Johnson, Katie S Murray, Hiroko Miyagi
Urologic Oncology. 2025-01-20 - Response to neoadjuvant chemotherapy leads to better survival outcomes in upper tract urothelial carcinoma.Alice Yu, Patrick J Hensley, Heather L Huelster, Austin Martin, Aaron Potrezke
BJU International. 2025-01-18
Press Mentions
- How I Turned My Kidney and Brain Cancer Diagnoses into Something MeaningfulMay 29th, 2019
- Telemedicine Extends Minimally Invasive Surgery’s BenefitsJanuary 13th, 2016
- ASCO GU 2020: Upper Tract Disease: Topical Therapy, Systemic TherapyFebruary 17th, 2020
- Join now to see all
Professional Memberships
- Member